About Porton

About Porton

With over 4,200 employees and 18 operations and commercial offices across the US, EU, and China, Porton Pharma Solutions provides global pharmaceutical and biotech companies with innovative, reliable, and end-to-end process R&D and GMP manufacturing services across Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products.

We are committed to a customer-centric approach and have been recognized through awards by industry forums and global pharmaceutical and biotech companies for our process innovation, supply chain performance, and compliance with global quality and EHS standards. We constantly strive for excellence and to enable the public's early access to good medicines.

Porton is publicly listed on the Shenzhen Stock Exchange (Ticker: 300363).

Visit PortonPharma.com